Literature DB >> 11131913

Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.

B A Feltis1, S M Wiesner, A S Kim, S L Erlandsen, D L Lyerly, T D Wilkins, C L Wells.   

Abstract

Clostridium difficile toxins A and B are the widely recognized etiologic agents of antibiotic-associated diseases ranging from diarrhea to pseudomembranous colitis. We hypothesized that C. difficile toxins may alter intestinal epithelial permeability and facilitate bacterial penetration of the intestinal epithelial barrier. Experiments were designed to clarify the effects of C. difficile toxins A and B on the flux of inert particles across HT-29 enterocyte monolayers, and to correlate these results with bacteria-enterocyte interactions. In all experiments, mature, confluent HT-29 cultures were preincubated 16 h with toxin A or B (1-100 ng/mL). To study alterations in epithelial permeability, toxin-treated enterocytes were incubated with 5 pM solutions of 10- and 40-kD inert dextran particles. Toxin A, but not toxin B, was associated with increased dextran flux through enterocyte monolayers. To study bacteria-enterocyte interactions, toxin-treated enterocytes were incubated with 10(8) Salmonella typhimurium, Proteus mirabilis, or Escherichia coli. Although numbers of internalized bacteria were generally unaffected, both toxins were associated with increased bacterial adherence, as well as increased bacterial transmigration through enterocyte monolayers. Bacterial transmigration was significantly greater using toxin A- compared to toxin B-treated enterocytes, consistent with the observation that dextran flux was significantly greater using toxin A- compared to toxin B-treated enterocytes. Thus intestinal colonization with toxigenic C. difficile may facilitate bacterial penetration of the intestinal epithelium by a mechanism involving increased permeability of the intestinal epithelial barrier.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131913     DOI: 10.1097/00024382-200014060-00010

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  16 in total

1.  Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.

Authors:  Lea M Spyres; Jeremy Daniel; Amy Hensley; Maen Qa'Dan; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  A small-molecule antivirulence agent for treating Clostridium difficile infection.

Authors:  Kristina Oresic Bender; Megan Garland; Jessica A Ferreyra; Andrew J Hryckowian; Matthew A Child; Aaron W Puri; David E Solow-Cordero; Steven K Higginbottom; Ehud Segal; Niaz Banaei; Aimee Shen; Justin L Sonnenburg; Matthew Bogyo
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

Review 3.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study.

Authors:  John Penders; Carel Thijs; Piet A van den Brandt; Ischa Kummeling; Bianca Snijders; Foekje Stelma; Hanne Adams; Ronald van Ree; Ellen E Stobberingh
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

5.  Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.

Authors:  Joseph M Sturino; Karina Pokusaeva; Robert Carpenter
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

6.  Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.

Authors:  Charles Darkoh; Heidi B Kaplan; Herbert L Dupont
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

Review 7.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

8.  Multiple factors contribute to bimodal toxin gene expression in Clostridioides (Clostridium) difficile.

Authors:  Eric M Ransom; Gabriela M Kaus; Phuong M Tran; Craig D Ellermeier; David S Weiss
Journal:  Mol Microbiol       Date:  2018-10-14       Impact factor: 3.501

9.  Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.

Authors:  Charles Darkoh; Herbert L Dupont; Heidi B Kaplan
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 10.  Toward a structural understanding of Clostridium difficile toxins A and B.

Authors:  Rory N Pruitt; D Borden Lacy
Journal:  Front Cell Infect Microbiol       Date:  2012-03-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.